Published 16 hours ago • loading... • Updated 7 hours ago
SMCI Investors Have Opportunity to Lead Super Micro Computer, Inc. Securities Fraud Lawsuit
The lawsuits allege Super Micro failed to disclose a scheme that diverted about $2.5 billion in servers to China, sending shares down 33.3%, lawyers said.
On Wednesday, May 6, 2026, The Rosen Law Firm and Bronstein, Gewirtz & Grossman, LLC announced a securities class action lawsuit against Regencell Bioscience Holdings Limited, alleging Defendants made materially false statements regarding operations and compliance policies.
The Class Period spans October 28, 2024, to October 31, 2025, covering investors who purchased Regencell securities. The lawsuit claims the Company failed to disclose vulnerabilities to market manipulation and significant financial risks.
Lead plaintiff applications must be filed with the Court by June 23, 2026. A lead plaintiff acts as a representative party directing the litigation on behalf of other class members.
The firms represent investors on a contingency fee basis, ensuring no out-of-pocket costs unless successful. Investors may select counsel of their choice or remain absent class members.
Interested parties can obtain information through the firms' websites. Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, emphasized their practice centers on "restoring investor capital and ensuring corporate accountability.